208 related articles for article (PubMed ID: 37662503)
1. Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?
Georgescu D; Ancusa OE; Azoulay D; Lascu A; Ionita I; Calamar-Popovici D; Ionita M; Rosca CI; Brează GM; Reisz D; Lighezan D
Int J Gen Med; 2023; 16():3889-3906. PubMed ID: 37662503
[TBL] [Abstract][Full Text] [Related]
2. Potential contribution of the gut microbiota to the development of portal vein thrombosis in liver cirrhosis.
Huang XY; Zhang YH; Yi SY; Lei L; Ma T; Huang R; Yang L; Li ZM; Zhang D
Front Microbiol; 2023; 14():1217338. PubMed ID: 37965548
[TBL] [Abstract][Full Text] [Related]
3. Analysis of related factors of portal vein thrombosis in liver cirrhosis.
Xu X; Jin J; Liu Y; Li H
BMC Gastroenterol; 2023 Jan; 23(1):26. PubMed ID: 36717769
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
Lin GS; Xu Q; Zhao SY; Zhang YX
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
[No Abstract] [Full Text] [Related]
5. [Correlational study on portal vein thrombosis of liver cirrhosis].
Xu DQ; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):573-579. PubMed ID: 32791792
[No Abstract] [Full Text] [Related]
6. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis.
Pan J; Wang L; Gao F; An Y; Yin Y; Guo X; Nery FG; Yoshida EM; Qi X
Eur J Intern Med; 2022 Oct; 104():21-32. PubMed ID: 35688747
[TBL] [Abstract][Full Text] [Related]
7. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.
Zampino R; Lebano R; Coppola N; Macera M; Grandone A; Rinaldi L; De Sio I; Tufano A; Stornaiuolo G; Adinolfi LE; Durante-Mangoni E; Battista GG; Niglio A
Saudi J Gastroenterol; 2018; 24(1):25-29. PubMed ID: 29451181
[TBL] [Abstract][Full Text] [Related]
8. Significance of altered anticoagulant proteins and D-dimer in cirrhotic portal vein thrombosis: relation to the degree of liver dysfunction.
Metawea M; El Wazzan D; El-Shendidi A
Clin Exp Hepatol; 2022 Sep; 8(3):233-242. PubMed ID: 36685270
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features and risk factors of portal vein thrombosis in 28 patients with antiphospholipid syndrome].
You HX; Zhao JL; Wang Q; Tian XP; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2019 Dec; 58(12):894-898. PubMed ID: 31775452
[No Abstract] [Full Text] [Related]
11. The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study.
Chen Z; Ran T; Cao H; Xu F; Zhou ZH; He S
Front Med (Lausanne); 2021; 8():685944. PubMed ID: 34262917
[No Abstract] [Full Text] [Related]
12. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients.
Cagin YF; Atayan Y; Erdogan MA; Dagtekin F; Colak C
Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):499-503. PubMed ID: 27733319
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical characteristics of advanced portal vein thrombosis in cirrhotic patients with gastroesophageal variceal hemorrhage.
Rao CY; Xue CY; Fang QQ; Wu L; Huang XQ; Chen Y; Chen SY; Li F
J Dig Dis; 2023 Apr; 24(4):284-292. PubMed ID: 37246244
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.
Gao Z; Li S; Zhao J; Li J; Gao Y
Intern Emerg Med; 2023 Mar; 18(2):513-521. PubMed ID: 36692588
[TBL] [Abstract][Full Text] [Related]
15. Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis.
Dong G; Huang XQ; Zhu YL; Ding H; Li F; Chen SY
Ann Transl Med; 2021 Feb; 9(4):289. PubMed ID: 33708916
[TBL] [Abstract][Full Text] [Related]
16. Portal vein thrombosis risk factors in liver transplant candidates.
Ak C; Adali G; Sayar S; Agackiran A; Kulali F; Kahraman R; Ozturk O; Ozdil K
Hepatol Forum; 2022 Sep; 3(3):88-92. PubMed ID: 36177096
[TBL] [Abstract][Full Text] [Related]
17. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
Abdel-Razik A; Mousa N; Elhelaly R; Tawfik A
Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
[TBL] [Abstract][Full Text] [Related]
18. Management of Chronic Portal Vein Thrombosis in a Cirrhotic Patient With Pancytopenia and Grade II Esophageal Varices.
Aziz AA; Yang D; Naeem M; Christmas D
Cureus; 2022 Jan; 14(1):e21150. PubMed ID: 35165600
[TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.
Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT
Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative risk factors of portal venous thrombosis after splenectomy and gastric pericardial devascularization for portal hypertension].
Han J; Yi Y; Ding H; Liu J; Zhang Y; Hu L; Zhao L; Liu T
Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):739-43. PubMed ID: 25496862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
